With expansion a prime focus for businesses worldwide, many are looking towards rapidly establishing new regions of growth, particularly in Asia, Pacifi c Rim countries.
The latest business developments from across Asia by Heather Hobbs To appear in our next issue, send your Business and Financial News stories to
heather@intlabmate.com
This section of International Labmate will especially look at the success of both Asian and European companies with established premises or business partnerships, highlighting the opportunities that exist while realising potential for other companies to move into export markets.
Sartorius Stedim Biotech Opens a New Validation Service Laboratory at Its Shanghai Site
Sartorius Stedim Biotech (SSB) have opened a new validation service laboratory at its site in Shanghai Zhangjiang Hi-Tech Park. The opening event was attended by business partners from the biopharmaceutical industry and representatives of the local community.
With its new laboratory, Sartorius Stedim Biotech is making validation of membrane fi lters even more convenient and time-saving. Chinese customers can have their entire process steps validated locally and will also benefi t from direct interaction with Sartorius specialists on site. “Our Shanghai validation lab provides high-quality services that are fully compliant with applicable GMP and GLP principles. At this validation service lab, we now offer comprehensive process validation studies for the strongly growing Chinese pharma market,” stated Dr Jörg Lindenblatt, SSB’s Senior Vice President of Sales for Bioprocess Solutions in Asia, in his opening speech. The validation lab, together with SSB’s Application Center in Shanghai, provides a full range of extended services to the biopharmaceutical industry.
SSB’s new Shanghai laboratory covers approximately 4,000ft2 (370m2). Equipped with the latest instrumentation, it offers microbiological testing services and physical- chemical testing to provide a full range of data for
Chiltern Expands Footprint in Bangalore to Meet Global Data Demand
Chiltern, a leading global contract research organisation, has announced the opening of its new process and technology centre in Bangalore, India. The new offi ce is a direct result of the company’s continued success and fulfi ls a need to further enhance its global data capabilities.
Opening of Sartorius Stedim Biotech’s new validation service laboratory in Shanghai: Dr Jörg Lindenblatt, SSB’s Senior Vice President of Sales for Bioprocess Solutions in Asia (4th from left), joined by business partners and colleagues in cutting the ribbon
process validation studies in compliance with all regulatory requirements. Certifi ed according to Biosafety Level II (BSL-2), the facility is permitted to handle specifi c critical bacteria and customer products.
41471pr@reply-direct.com
“We believe we have compiled one of the best teams in the industry,” said Mark Penniston, Executive Vice President, Clinical Analytics, and General Manager at Chiltern. “We need this facility to maintain pace with our continued growth, and having an offi ce in the heart of the city provides shorter commutes and a better quality of life for our industry-leading employees.”
The fi rst Chiltern offi ce in India opened more than a decade ago with fi ve programmers. In total, the company’s offi ces in India will be able to support more than 600 employees and give Chiltern substantial capacity to advance operations as needed.
Future Global Economy Trends Point to Opportunities
for Companies with Right Approach The long-term global economic power shift away from the established advanced economies is set to continue over the period to 2050, as emerging market countries continue to boost their share of world GDP in the long run despite recent mixed performance in some of these economies.
This is one of the key fi ndings from a report from PwC economists on the theme of ‘the World in 2050: The Long View: how will the global economy order change by 2050?’ This presents projections of potential GDP growth up to 2050 for 32 of the largest economies in the world, which together account for around 85% of global GDP. These projections are based on the latest update of a detailed long-term global growth model fi rst developed by PwC in 2006.
The report projects that the world economy could double in size by 2042, growing at an annual average real rate of around 2.5% between 2016 and 2050. This growth will be driven largely by emerging market and developing countries, with the E7 economies of Brazil, China, India, Indonesia, Mexico, Russia and Turkey growing at an annual average rate of around 3.5% over the next 34 years, compared to only around 1.6% for the advanced G7 nations of Canada, France, Germany, Italy, Japan, the UK and the US.
John Hawksworth, PwC Chief Economist and co-author of the report, commented: “We will continue to see the shift in global economic power away from established advanced economies towards emerging economies in Asia and elsewhere. The E7 could comprise almost 50% of world GDP by 2050, while the G7’s share declines to only just over 20%”
Deepankar Sanwalka, Leader- Advisory, PwC India commented: “This shift in global economic power to emerging economic economies is one of the most relevant and pronounced megatrends for India. The confi dence of Indian CEOs about their company’s prospects and the kind of new business opportunities we see in India today is a testimonial of that trend. The growth we are aspiring for and gearing up to witness will have to be sustainable, inclusive and technology enabled.”
The report predicts great opportunities for businesses with the right strategic mix of fl exibility and patience to succeed in these emerging markets. Case studies in the PwC report illustrate how businesses should be prepared to adjust their brand and market positions to suit differing and often more nuanced local preferences. An in-depth understanding of the local market and consumers will be crucial, which will often involve working with local partners.
“Businesses need to be patient enough to ride out the short-term economic and political storms that will inevitably occur from time to time in these emerging markets as they move towards maturity. But the numbers in our report make clear that failure to engage with these emerging markets means missing out on the bulk of the economic growth we expect to see in the world economy between now and 2050,” John Hawksworth concluded.
More details on business strategies for emerging markets can be found in reports by the PwC Growth Markets Centre, which are available on
www.pwc.com
42038pr@reply-direct.com
The process and technology centre in India also increases Chiltern’s existing 24-hour global presence, positioning data teams in time zones around the world. Chiltern’s process and technology teams around the globe, including Central and Eastern Europe, Latin America and Asia - composed of more than 1,600 data professionals supporting analytics, risk-based optimisation, biometrics and pharmacovigilance - continually improve data quality and speed and reduce costs for clients everywhere.
42010pr@reply-direct.com
IDT Completes Acquisition
of Geneworks Integrated DNA Technologies has, through its Singapore subsidiary, completed the acquisition of the oligonucleotide manufacturing business of GeneWorks Pty Ltd. in Australia. This acquisition sees IDT expand its reach in the Asia-Pacifi c region, following its recent establishment of sales offi ces in Japan and Korea.
Dr Joseph A Walder, IDT founder and CEO, commented, “With this acquisition, we are furthering our goal of making our world-class products and services more easily accessible to scientists around the world. We look forward to availing GeneWorks’ customers of our unrivalled manufacturing capabilities, design expertise, and fast turnaround times.”
41859pr@reply-direct.com
Does your company sell or wish to sell laboratory products and services to the economies of Asia? Are you looking for local distributors and agents to represent you?
If so, why not advertise your products in our market- leading journal International Labmate.
Email:
info@intlabmate.com
Business
Opportunities Asia
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
